Capparis Moonii

Capparis moonii  Wight.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Capparidaceae.
Habitat Indigenous to New Zealand. Now distributed in Karnataka and Tamil Nadu.
Ayurvedic Rudanti.
Action Fruit—used in puerperal sepsis and septic wounds, also for debility and cough.
Taxonomic Cohort Genus Capparis (5 documented species); Family Capparidaceae (9 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Capparis moonii (taxonomically cited with authority Wight.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Capparidaceae (primary family classification: Capparidaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Indigenous to New Zealand. Now distributed in Karnataka and Tamil Nadu.

Across classical and vernacular Indian systems of medicine, Capparis moonii is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Rudanti. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Capparis moonii are: Fruit—used in puerperal sepsis and septic wounds, also for debility and cough. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Capparis moonii establish the following evidence base: EtOH (50%) extract of aerial parts is CNS depressant. Fruits contain l-stachydrine, rutin and beta-sitosterol.

image2

Botanical Reference 1: Capparis moonii — Botanical specimen

image3

Botanical Reference 2: Capparis moonii — Botanical specimen

image4

Botanical Reference 3: Capparis moonii — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Capparis comprises 5 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Capparis aphylla (Action: Anti-inflammatory (used for enlarged cervical glands, sciatica, rheumatoid…); Capparis sepiaria (Action: Antiseptic, antipyretic. Used for eczema and scabies); Capparis spinosa (Action: Anti-inflammatory, deobstruent to liver and spleen, diuretic, anthelmintic…); Capparis zeylanica (Action: Root bark—sedative, stomachic, anticholerin, diuretic febrifuge. Leaves—applied…). Comparing Capparis moonii alongside its congeners in genus Capparis highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Capparidaceae encompasses 9 documented medicinal species (0.50% of the 1,814-species flora). Other representative medicinal members of Capparidaceae include: Cadaba fruticosa (Kodhab), Capparis aphylla (Karira), Capparis sepiaria (Himsraa), Cleome brachycarpa (Madhio), Crataeva nurvala (Varuna). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 9 medicinal species of family Capparidaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Capparis moonii follow the plant-part modalities specified under its therapeutic action (Fruit—used in puerperal sepsis and septic wounds, also for debility and cough), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Capparis moonii integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top